Literature DB >> 1474251

A simplified method for determination of peptide-protein molar ratios using amino acid analysis.

K R Shuler1, R G Dunham, P Kanda.   

Abstract

In this report, we have described methods to improve the efficiency of coupling synthetic peptides to keyhole limpet hemocyanin (KLH) and for the analysis of the composition of the resulting peptide-protein conjugates. KLH was first dissolved in buffers containing 3 M guanidine hydrochloride to maintain solubility and derivatized with either of two water soluble, heterobifunctional crosslinkers, m-maleimido-benzoyl-N-hydroxy-sulfosuccinimide ester (SMBS), or sulfosuccinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SSMCC) (300:1 molar excess over KLH). Synthetic peptides containing an amino terminal cysteine were then crosslinked to the modified KLH via sulfhydryl reaction with the crosslinker maleimide groups. Following dialysis to remove free peptide, the amino acid composition of the conjugate was determined. The molar ratio of peptide to protein within the conjugate was obtained by comparing the conjugate composition with that of both the KLH and peptide analyzed separately, and by a multiple regression, least squares analysis of the data. This method is generally applicable to the analysis of the molar ratios of protein-protein conjugates of unknown sequence or composition, and requires only the prior determination of the experimental amino acid composition of each component of the conjugate separately.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1474251     DOI: 10.1016/0022-1759(92)90020-t

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  12 in total

1.  Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complex.

Authors:  Yimin Wu; Craig Przysiecki; Elizabeth Flanagan; Sheila N Bello-Irizarry; Roxana Ionescu; Olga Muratova; Gelu Dobrescu; Lynn Lambert; David Keister; Yvette Rippeon; Carole A Long; Li Shi; Michael Caulfield; Alan Shaw; Allan Saul; John Shiver; Louis H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-16       Impact factor: 11.205

2.  Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor.

Authors:  Elisabetta Bianchi; Xiaoping Liang; Paolo Ingallinella; Marco Finotto; Michael A Chastain; Jiang Fan; Tong-Ming Fu; Hong Chang Song; Melanie S Horton; Daniel C Freed; Walter Manger; Emily Wen; Li Shi; Roxana Ionescu; Colleen Price; Marc Wenger; Emilio A Emini; Riccardo Cortese; Gennaro Ciliberto; John W Shiver; Antonello Pessi
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

3.  Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines.

Authors:  Puthupparampil V Scaria; Chris G Rowe; Beth B Chen; Thayne H Dickey; Jonathan P Renn; Lynn E Lambert; Emma K Barnafo; Kelly M Rausch; Niraj H Tolia; Patrick E Duffy
Journal:  iScience       Date:  2022-07-09

4.  Determination of protein concentration for protein-protein conjugates using ultraviolet absorption.

Authors:  Daming Zhu; Feng Qian; Yimin Wu; David S Jones; Christopher Rowe; David L Narum; Patrick Duffy; Louis H Miller; Allan Saul
Journal:  J Immunol Methods       Date:  2012-10-23       Impact factor: 2.303

5.  Enhanced antibody responses to Plasmodium falciparum Pfs28 induced in mice by conjugation to ExoProtein A of Pseudomonas aeruginosa with an improved procedure.

Authors:  Feng Qian; Joan A Aebig; Karine Reiter; Emma Barnafo; Yanling Zhang; Richard L Shimp; Kelly M Rausch; David S Jones; Daming Zhu; Lynn Lambert; Gregory E D Mullen; David L Narum; Louis H Miller; Yimin Wu
Journal:  Microbes Infect       Date:  2008-12-27       Impact factor: 2.700

6.  Quantification of residual hydrophobic fusion peptide with monomer and dimer forms using reversed-phase liquid chromatography.

Authors:  Cindy X Cai; Nicole A Schneck; Vera B Ivleva; Krishana Gulla; Yaqiu Zhang; Daniel Gowetski; Q Paula Lei
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2020-03-19       Impact factor: 3.205

7.  Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25.

Authors:  Joanna Kubler-Kielb; Fathy Majadly; Yimin Wu; David L Narum; Chunyan Guo; Louis H Miller; Joseph Shiloach; John B Robbins; Rachel Schneerson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-26       Impact factor: 12.779

8.  Immunogenicity of self-associated aggregates and chemically cross-linked conjugates of the 42 kDa Plasmodium falciparum merozoite surface protein-1.

Authors:  Feng Qian; Karine Reiter; Yanling Zhang; Richard L Shimp; Vu Nguyen; Joan A Aebig; Kelly M Rausch; Daming Zhu; Lynn Lambert; Gregory E D Mullen; Laura B Martin; Carole A Long; Louis H Miller; David L Narum
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

9.  Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle.

Authors:  Richard L Shimp; Christopher Rowe; Karine Reiter; Beth Chen; Vu Nguyen; Joan Aebig; Kelly M Rausch; Krishan Kumar; Yimin Wu; Albert J Jin; David S Jones; David L Narum
Journal:  Vaccine       Date:  2013-04-24       Impact factor: 4.169

10.  Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidates.

Authors:  Feng Qian; Yimin Wu; Olga Muratova; Hong Zhou; Gelu Dobrescu; Peter Duggan; Lambert Lynn; Guanhong Song; Yanling Zhang; Karine Reiter; Nicholas MacDonald; David L Narum; Carole A Long; Louis H Miller; Allan Saul; Gregory E D Mullen
Journal:  Vaccine       Date:  2007-03-13       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.